comparemela.com

Latest Breaking News On - Diagnostic oncology - Page 1 : comparemela.com

Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber's Adult Oncology Program

Arthur T. Skarin, MD, Physician-Scientist Instrumental in Building Dana-Farber's Adult Oncology Program
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Dana-farber-cancer-institute
Massachusetts
United-states
Boston
Charlestown
Texas
Amarillo
Bruce-johnson
Arthurt-skarin
Jonk-skarin
Matthewa-skarin
Kathleen-glunz-skarin

VolitionRx Taking on Nucleosome-Focused Dx for Human Cancers After Canine Cancer Screening Test

The firm is working with MD Anderson Cancer Center to show that its NETosis test can predict which cancer patients are at risk for sepsis.

Nevada
United-states
Switzerland
Swiss
Santersu-nucleocapture
Jake-micallef
Drug-administration
Md-anderson-cancer-center
Cancer-center
Diagnostic-oncology

VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update

VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Nevada
United-states
United-kingdom
Texas
Singapore
Belgium
California
Canada
London
City-of
America
Louise-batchelor-debra-daglish

VolitionRx Limited Announces Second Quarter 2022 Financial Results and Business Update

/PRNewswire/ VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition") today announced financial results and a business update for the second quarter ended June.

Nevada
United-states
United-kingdom
Texas
Singapore
Belgium
California
Canada
London
City-of
America
Louise-batchelor-debra-daglish

VolitionRx Limited appoints DXOCRO to undertake development and clinical validation studies for its Nu.Q product portfolio in the US

VolitionRx (NYSE-A:VNRX) Limited said it has appointed Diagnostic Oncology CRO, LLC (DXOCRO) to undertake development and clinical validation studies for.

United-states
London
City-of
United-kingdom
Singapore
Belgium
Sharon-ballesteros
Breakthrough-devices-program
Drug-administration
Diagnostic-oncology
United-states-food
Devices-program

vimarsana © 2020. All Rights Reserved.